⚠️ Disclaimer

Melanotan II is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.

The most common research dosage for Melanotan II is 250-500 mcg per injection, administered every other day via subcutaneous injection. Typical cycles run 2-4 weeks for tanning effects. With a half-life of not precisely established; effects persist longer than MT-I, timing matters for optimal results.

What Is Melanotan II and Why Does Dosing Matter?

Melanotan II (Melanotan II (cyclic α-MSH analog)) is a Non-selective melanocortin receptor agonist. Synthetic cyclic α-MSH analog with non-selective activity across MC1, MC3, MC4, and MC5 receptors. Getting the dosage right is critical — too little may produce no measurable effect, while excessive amounts increase risk without proportional benefit.

The standard research dosage for Melanotan II has been established through preclinical studies and community protocols. This guide covers the evidence-backed dosing range, timing, and cycle structure.

The most widely used Melanotan II dosage is 250-500 mcg per injection, administered every other day via subcutaneous injection.

Beginners should start at the lower end of this range and titrate upward only if needed. The half-life of Melanotan II is not precisely established; effects persist longer than MT-I, which directly determines how often you need to dose to maintain stable blood levels.

For Melanotan II specifically, the 2-4 weeks for tanning effects cycle length is standard. Longer isn't always better — Non-selective melanocortin receptor agonist compounds require cycling to maintain receptor sensitivity.

When Should You Dose Melanotan II?

With a half-life of not precisely established; effects persist longer than MT-I, timing your Melanotan II administration affects peak blood levels. Most protocols call for every other day.

For peptides administered before bed (common with GH-related compounds), the goal is to amplify the natural nocturnal growth hormone pulse. For healing peptides, proximity to the injury site via local injection can improve outcomes.

Calculate Your Melanotan II Dose

Use our free peptide dosing calculator to get exact reconstitution math and syringe units for Melanotan II.

Open Calculator →

How Do You Reconstitute Melanotan II?

Melanotan II typically comes as a lyophilized (freeze-dried) powder. Reconstitute with bacteriostatic water — never saline or sterile water, as BAC water contains 0.9% benzyl alcohol that prevents bacterial growth and extends shelf life to 4-6 weeks.

Use our peptide dosing calculator to determine the exact amount of BAC water to add based on your vial size and desired dose per injection.

How Long Should a Melanotan II Cycle Last?

Standard Melanotan II cycles run 2-4 weeks for tanning effects. This timeframe is based on the compound's mechanism and the time needed to observe measurable effects.

Limited formal clinical trials. One pilot Phase I study documented tanning and sexual effects but raised significant safety concerns. Most evidence comes from case reports of serious adverse events. Banned in multiple countries.

What Side Effects Can Affect Dosing?

Extensive adverse effects: nausea, vomiting, facial flushing, involuntary erections, yawning, loss of appetite. Serious reports of rhabdomyolysis, renal infarction, posterior reversible encephalopathy syndrome, and sympathomimetic toxicity. Increased melanoma risk, atypical moles, melanonychia (nail darkening). Dose-dependent toxicity.

If side effects emerge, the first step is typically reducing the dose rather than discontinuing entirely. Most Melanotan II-related side effects are dose-dependent.

How Does Melanotan II Dosing Change When Stacking?

Not recommended for stacking due to serious safety profile and non-selective receptor activation.

When stacking, some researchers reduce individual peptide doses by 20-30% since synergistic effects mean full doses of each aren't always necessary.

What Is the Bottom Line on Melanotan II Dosing?

Start at 250, dose every other day, and run cycles of 2-4 weeks for tanning effects. Monitor your response and adjust within the established range.

Source matters — always use research-grade Melanotan II from vendors with third-party COA testing. Underdosed or contaminated products are the most common reason for poor results.

Complete Guide

Melanotan II: Research

Read the Full Guide →

Related Reading

Research-Grade Sourcing

If you're going to research Melanotan II, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.

Ascension → Browse Melanotan II

Particle → Browse Melanotan II

Frequently Asked Questions

What is Melanotan II?

Melanotan II (Melanotan II (cyclic α-MSH analog)) is a Non-selective melanocortin receptor agonist. Synthetic cyclic α-MSH analog with non-selective activity across MC1, MC3, MC4, and MC5 receptors. It is researched for rapid skin darkening, appetite suppression, erectile function enhancement, increased libido.

What is the recommended Melanotan II dosage?

Common dosages: 250-500 mcg per injection administered every other day via subcutaneous injection. Cycle length: 2-4 weeks for tanning effects. Half-life: not precisely established; effects persist longer than MT-I. Use our peptide calculator for exact reconstitution math.

What are the side effects of Melanotan II?

Extensive adverse effects: nausea, vomiting, facial flushing, involuntary erections, yawning, loss of appetite. Serious reports of rhabdomyolysis, renal infarction, posterior reversible encephalopathy syndrome, and sympathomimetic toxicity. Increased melanoma risk, atypical moles, melanonychia (nail darkening). Dose-dependent toxicity.

Is Melanotan II safe?

Melanotan II has shown a preliminary safety profile in research. Not FDA-approved. Banned for human use in many jurisdictions. Warnings issued by US FDA, UK MHRA, and other health agencies. WADA banned. All research should follow appropriate safety protocols.